Bio-Rad, Bruker Deal Links SELDI and MALDI-TOF/TOF Platforms

In a competitive field where deals linking two mass-spec technologies from different vendors are unusual, the partnership could help Bio-Rad make relevant a technology that has failed to capture the interest of the research community.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.